ENHANCED GLP-1 CARE TRACK

Omada’s GLP-1 Companion 
Program
Maximizes your 
GLP-1 Spend

The Essential GLP-1 Companion Program

Support your population across the medication lifecycle.

Before
Support members considering GLP-1s with expert coaching.
Who Should be Prescribed GLP-1s for Weight Loss? 
Watch Now
230501_GLP-1_Video Blog_1_Intro - Video 4_2023-10-27_17-13-37
During
Bolster weight loss with holistic lifestyle and exercise support.
How to Combat Muscle Loss While Taking GLP-1s
ProofPoints_Graphics_February_TitleGraphic-1
After
Tailor guidance for healthier body composition during and after GLP-1 use.
Life After GLP-1s: How to Prevent Weight Regain in Your Population
Resource Center 1040x566 (2)

See how Omada optimizes care for members taking
GLP-1 medications

Built on insights from 150k+ GLP-1 members, Omada’s Enhanced GLP-1 Care Track delivers the engagement support and clinical rigor that help optimize and sustain lasting outcomes, while fitting seamlessly into your benefit design. Through our integration with national PBMs and health plans—2,000+ clients with 200M benefit-eligible lives, our platform is designed to scale.

 

NEW OFFERING

Introducing guided medication care: Built for success, not just access.

Omada's industry-leading lifestyle and behavior change platform now includes integrated prescribing* for complete GLP-1 care.

 
B2B_GLP-1_New Offering_Care model

Cost Model

Individualized care informed by insights from 150K+ GLP-1 members.

B2B_GLP-1_New Offering_Integrated platform

Integrated Platform

Prescribing and proven lifestyle support — integrated by design, delivered as one.

B2B_GLP-1_New Offering_Coverage flexibility

Coverage Flexibility 

Narrow network or cash pay options to fit your benefit strategy.

Clinical-Grade Lifestyle Support

Omada’s behavior change expertise has been honed over 14+ years helping more than 2 million members manage chronic conditions, such as obesity. We believe GLP-1 success isn’t just about prescribing medication — that’s why our GLP-1 companion program supports members with managing side effects, adjusting nutrition, preserving muscle mass, and navigating the emotional highs and lows of a changing body and routine.

Exercise guidance
Exercise Guidance

Customized exercise plans** to remove movement barriers and help maintain muscle mass during weight loss.

BH tools
Behavioral Health Tools

Evidence-based approaches and self-help techniques rooted in cognitive behavioral therapy and mindfulness.

Medication persistence
Medication Persistence

Wrap-around support for side-effect management, injection guidance, medication access and care plan adherence. 

Personalized care
Personalized Care

Dedicated health coach and CDCES, plus access to an Exercise Specialist** and our GLP-1 member navigation team.

Nutrition support
Nutrition & Activity Coaching

Tailored coaching focused on hydration, protein and nutrient density, plus access to our food hub for tracking, insights and guidance through OmadaSpark’s AI chat. 

Education and community
Education & Community

GLP-1 specific learning paths, on-demand resources, and peer support communities.

Omada Health

Omada Health
Contact Sales to Learn More

Evidence-backed GLP-1 Care for Ongoing Success

Omada’s proven behavior change program has led to sustainable outcomes during and after GLP-1 use.

  • 67% of Enhanced GLP-1 Care Track members were persistent on their medication at 12 months, compared to 47-49% from real-world evidence.

  • Those members who persisted on their medication through 12 months experienced an average weight loss of 18.4%, compared to 11.9% average weight loss in real world evidence.

  • Members who discontinued their medication prior to 12 months still experienced more average weight loss than real world evidence at the 12-month mark (13.1% vs 6.8%).

  • 0.8% average weight change at 1 year after GLP-1 discontinuation, compared to an estimated average of 11-12% weight gain in clinical trials.

     

  • 63.2% of members maintained or continued to lose weight at 1 year after GLP-1 discontinuation.

Chart1
Chart2-1

Omada’s Enhanced GLP-1 Care Track: 
Smarter GLP-1 spend. Results that last.

Omada’s GLP-1 companion program can deliver outcomes and reduce cost exposure.

GainInsights

Gain insights through timely data and reporting

Recent data from Omada Insights Lab’s ANSWERS Initiative suggests that medication persistence, rather than early discontinuation, is key to GLP-1 cost containment.

Understand How to Better Manage GLP-1 Costs

SupportYourPopulation

Support your population with tailored GLP-1 care

Members enjoy a personal relationship with their multidisciplinary care team, including Cardiometabolic (CDCES) and Exercise Specialists.

Discover Strategies to Prevent Muscle Loss with GLP-1 Care

OfferASolution

Offer a solution with proven outcomes

Our GLP-1 companion program has led to sustained weight maintenance outcomes post- GLP-1 use that outperform clinical trial results.

Learn How Omada helps Sustain Weight Loss Post GLP-1 Usage

FAQs

How does Omada’s Enhanced GLP-1 Care Track influence weight loss outcomes?

According to the study Early GLP-1 Care Outcomes: Setting the Stage for Long-Term Weight Health, individuals in the Enhanced GLP-1 Care Track achieved a remarkable 28% average greater weight loss compared to those who met similar eligibility criteria and were not in the Care Track. This result was statistically significant (p<0.001), indicating that tailored GLP-1 support can be effective in boosting weight loss outcomes.

A popular industry solution has been to off-ramp patients as soon as possible to relieve payers of short-term prescription costs. However, recent data from Omada Insights Lab’s ANSWERS Initiative suggests that medication persistence, rather than early discontinuation, is key to GLP-1 cost containment and ROI.

In this ~2-minute video, Omada summarizes findings of our July 2025 clinical white paper: GLP-1 Persistence: A Key Component of Weight Loss.

Behavior change and lifestyle support is essential in obesity care, especially for people taking GLP-1s, as it can address long-term health concerns like potential muscle loss and reduced metabolism. Effective programs encourage healthy habits like resistance training to maintain weight loss and improve metabolic health, particularly after discontinuing GLP-1 medications. Omada Health provides guidance to help individuals sustain these lifestyle changes for lasting benefits.

To learn more about

  • Why GLP-1s are not a silver bullet for obesity
  • The role of behavior change support teams and how they complement obesity medicine specialists
  • How providers can work in concert to achieve optimal outcomes

 

Read 3 Reasons Behavior Change Support is Vital to Obesity Care



Become an Omada Insider
Sign Up

1. Omada Brief Report: Weight Health at One Year

2. Omada White Paper: Weight Maintenance Is Possible After GLP-1s—With the Right Support

*Prescriptions provided by a third-party provider partner.

** Exercise specialists are assigned to members once they indicate via a standard PAR-Q assessment that it is safe to exercise.

Images used are not real members. Testimonials are based on members’ real experiences and individual results. We do not claim that these are typical results that members will achieve. Results may vary.

The no cost CGM sensors exclude Medicare, Medicaid, and other government payers. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. For full FreeStyle Libre 3 Plus sensor safety information, please visit https://www.freestyle.abbott/us-en/safety-information.html